Endokrinologi
Här hittar du videomaterial med nationella och internationella experter samt rapporter från stora kongresser och möten.
daniel olsson
Surgical resection goal in NFPAs - Does it relate to the extent of resection?
ENDO 2019, Dr Daniel Olsson, Sahlgrenska University Hospital, Gothenburg, Sweden
Cardiometabolic abnormalities in acromegalic patients
ENDO 2019, Dr Daniel S Olsson, Sahlgrenska Universitetssjukhuset, Göteborg
Two new ways of using copeptin to discriminate between primary polydipsia and diabetes insipidus
ENDO 2018. Dr. Daniel S Olsson, Sahlgrenska Universitetssjukhuset i Göteborg.
Can klotho be a new biomarker in patients with acromegaly?
ENDO 2018. Dr. Daniel S Olsson, Sahlgrenska Universitetssjukhuset i Göteborg.
Mortality in Acromegaly, a Swedish Nationwide Study
ENDO 2018. Dr. Daniel S. Olsson, Sahlgrenska Universitetssjukhuset i Göteborg.
Dr. Olsson on Oxytocin levels in patients with craniopharyngioma
ENDO 2017. Dr. Daniel S. Olsson, Sahlgrenska Universitetssjukhuset i Göteborg.
Dr. Olsson on new possible drug targets for craniopharyngioma
ENDO 2017. Dr. Daniel S. Olsson, Sahlgrenska Universitetssjukhuset i Göteborg.
Dr. Olsson on the incidence of malignancies in NFPA patients
ENDO 2017. Dr. Daniel Olsson pratar om de mest intressanta delarna av kongressen.